Can we Really use Viruses to Treat Prostate Cancer?

Presenter: Dr. Jean-Simon Diallo
Original Date: Tuesday, April 5, 2016

Join Dr. Diallo to learn about: 

  • Basic cancer biology
  • Oncolytic virotherapy and oncolytic vaccines
  • Prostate cancer progression/treatment
  • How we are aiming to treat prostate cancer using our novel oncolytic vaccine approach

Dr. Jean-Simon Diallo's Biography:

Dr. Jean-Simon Diallo obtained his Master’s degree in Biochemistry at McGill University and his Ph.D in molecular biology at the Université de Montréal, where he studied natural compounds to treat prostate cancer and bio-markers to predict prostate cancer outcome. During his postdoctoral fellowship, Dr. Diallo worked on using oncolytic viruses to treat cancer and discovered a host of “viral sensitizer” molecules that enhance viral infection. Since 2012, he has been a Scientist at the Ottawa Hospital Research Institute. Working within a national network of collaborators, he and his team are working to improve virus-based therapeutics for the treatment of cancer and other diseases, by combining them with an increasing collection of novel “viral sensitizer” small molecules.

Expert AngleAbout Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.

Click here for news archive